Reclassifying CBD as MedicineIn December of last year, Australia’s Therapeutic Goods Administration (TGA) announced it was down-scheduling low-dose cannabidiol (CBD) from Schedule 4 (Prescription Only Medicine) to Schedule 3 (Pharmacist Only Medicine)(1). This means that soon, ...